Dr. reddy's laboratories announces the launch of a generic version of sapropterin dihydrochloride powder for oral solution, 100 mg in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of sapropterin dihydrochloride powder for oral solution, 100 mg, a therapeutic equivalent generic version of kuvan® (sapropterin dihydrochloride) powder for oral solution, 100 mg, usp, approved by the u.s. food and drug administration (usfda). “we are pleased to lau
RDY Ratings Summary
RDY Quant Ranking